Glenmark Pharmaceuticals Limited (BOM:532296)
2,648.00
+27.00 (1.03%)
At close: Nov 20, 2026
Glenmark Pharmaceuticals Market Cap
Glenmark Pharmaceuticals has a market cap or net worth of 747.33 billion as of November 20, 2026. Its market cap has increased by 43.86% in one year.
Market Cap
747.33B
Enterprise Value
748.49B
Revenue
159.97B
Global Rank
n/a
Country Rank
n/a
PE Ratio
51.51
ChartMarket Cap Chart
Since June 7, 2001, Glenmark Pharmaceuticals's market cap has increased from 1.15B to 747.33B, an increase of 64,924.70%. That is a compound annual growth rate of 28.96%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 747.33B | 30.12% |
| Dec 31, 2025 | 574.34B | 26.49% |
| Dec 31, 2024 | 454.07B | 88.44% |
| Dec 29, 2023 | 240.96B | 101.33% |
| Dec 30, 2022 | 119.68B | -19.75% |
| Dec 31, 2021 | 149.14B | 7.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Laurus Labs | 1.24T |
| Zydus Lifesciences | 1.20T |
| Cipla | 1.14T |
| Mankind Pharma | 1.10T |
| Aurobindo Pharma | 1.04T |
| Glenmark Pharmaceuticals | 747.33B |
| Alkem Laboratories | 619.94B |
| Gland Pharma | 549.34B |